| Cancer phase I clinical trials: efficient dose escalation with overdose control J Babb, A Rogatko, S Zacks Statistics in medicine 17 (10), 1103-1120, 1998 | 738 | 1998 |
| International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity AD Auerbach, A Rogatko, TM Schroeder-Kurth | 440 | 1989 |
| UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan LE Carlini, NJ Meropol, J Bever, ML Andria, T Hill, P Gold, A Rogatko, ... Clinical Cancer Research 11 (3), 1226-1236, 2005 | 353 | 2005 |
| Prognosis of pregnancy‐associated breast cancer JA Petrek, R Dukoff, A Rogatko Cancer 67 (4), 869-872, 1991 | 340 | 1991 |
| Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women J Sheinfeld, AJ Schaeffer, C Cordon-Cardo, A Rogatko, WR Fair New England Journal of Medicine 320 (12), 773-777, 1989 | 333 | 1989 |
| Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification N Nese, G Martignoni, CD Fletcher, R Gupta, CC Pan, H Kim, JY Ro, ... The American journal of surgical pathology 35 (2), 161-176, 2011 | 324 | 2011 |
| Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model JD Cheng, RL Dunbrack Jr, M Valianou, A Rogatko, RK Alpaugh, ... Cancer research 62 (16), 4767-4772, 2002 | 317 | 2002 |
| Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma SJ Cohen, RK Alpaugh, I Palazzo, NJ Meropol, A Rogatko, Z Xu, ... Pancreas 37 (2), 154-158, 2008 | 287 | 2008 |
| In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots MV Yezhelyev, A Al-Hajj, C Morris, AI Marcus, T Liu, M Lewis, C Cohen, ... ADVANCED MATERIALS-DEERFIELD BEACH THEN WEINHEIM- 19 (20), 3146, 2007 | 272 | 2007 |
| Translation of innovative designs into phase I trials A Rogatko, D Schoeneck, W Jonas, M Tighiouart, FR Khuri, A Porter Journal of Clinical Oncology 25 (31), 4982-4986, 2007 | 270 | 2007 |
| Changing patterns of bone and brain metastases in patients with colorectal cancer ML Sundermeyer, NJ Meropol, A Rogatko, H Wang, SJ Cohen Clinical colorectal cancer 5 (2), 108-113, 2005 | 266 | 2005 |
| Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma MS Brady, A Rogatko, LL Dent, MH Shiu Archives of surgery 126 (3), 359-364, 1991 | 241 | 1991 |
| Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer SJ Cohen, RK Alpaugh, S Gross, SM O'Hara, DA Smirnov, ... Clinical colorectal cancer 6 (2), 125-132, 2006 | 233 | 2006 |
| The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. RN Younes, A Rogatko, MF Brennan Annals of surgery 214 (2), 107, 1991 | 223 | 1991 |
| Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis S Josson, M Gururajan, SY Sung, P Hu, C Shao, HE Zhau, C Liu, ... Oncogene 34 (21), 2690-2699, 2015 | 222 | 2015 |
| Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma SJ Cohen, L Ho, S Ranganathan, JL Abbruzzese, RK Alpaugh, M Beard, ... Journal of Clinical Oncology 21 (7), 1301-1306, 2003 | 220 | 2003 |
| Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. DG Coit, A Rogatko, MF Brennan Annals of surgery 214 (5), 627, 1991 | 211 | 1991 |
| A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve CN Bairey Merz, EM Handberg, CL Shufelt, PK Mehta, MB Minissian, ... European heart journal 37 (19), 1504-1513, 2016 | 209 | 2016 |
| The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7. 1) in patients with … M von Mehren, P Arlen, J Gulley, A Rogatko, HS Cooper, NJ Meropol, ... Clinical cancer research 7 (5), 1181-1191, 2001 | 208 | 2001 |
| Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7. 1 transgenes in patients with recurrent CEA-expressing adenocarcinomas M von Mehren, P Arlen, KY Tsang, A Rogatko, N Meropol, HS Cooper, ... Clinical cancer research 6 (6), 2219-2228, 2000 | 204 | 2000 |
